Inhibitory effects of angiotensin-(1-7) on the nerve stimulation-induced release of norepinephrine and neuropeptide Y from the mesenteric arterial bed

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 298, Issue 2, 2010, Pages

  Byku, Mirnela ^a   Macarthur, Heather ^a   Westfall, Thomas C ^a  

^a SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Bradykinin; Mesenteric artery; Nitric oxide; Sympathetic neurotransmission

Indexed keywords

1 (4 DIMETHYLAMINO 3 METHYLBENZYL) 5 DIPHENYLACETYL 4,5,6,7 TETRAHYDRO 1H IMIDAZO[4,5 C]PYRIDINE 6 CARBOXYLIC ACID; ADENOSINE TRIPHOSPHATE; ANGIOTENSIN 2 RECEPTOR; ANGIOTENSIN II; ANGIOTENSIN[1-7][7 DEXTRO ALANINE]; N(G) NITROARGININE METHYL ESTER; NEUROPEPTIDE Y; NORADRENALIN;

ADRENERGIC SYSTEM; ADRENERGIC TRANSMISSION; ANIMAL TISSUE; ANTIHYPERTENSIVE ACTIVITY; ARTICLE; CONTROLLED STUDY; HYPERTENSION; MALE; MESENTERIC ARTERY; NERVE STIMULATION; NEUROTRANSMITTER RELEASE; NONHUMAN; NORADRENALIN RELEASE; PERFUSION PRESSURE; PRIORITY JOURNAL; RAT; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SPONTANEOUSLY HYPERTENSIVE RAT; SYMPATHETIC NERVE;

ANGIOTENSIN I; ANIMALS; ANTIHYPERTENSIVE AGENTS; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTRIC STIMULATION; HYPERTENSION; IMIDAZOLES; MALE; MESENTERIC ARTERIES; NEUROPEPTIDE Y; NG-NITROARGININE METHYL ESTER; NOREPINEPHRINE; PEPTIDE FRAGMENTS; PYRIDINES; RATS; RATS, INBRED SHR; RATS, INBRED WKY; RECEPTOR, ANGIOTENSIN, TYPE 2; SYMPATHETIC NERVOUS SYSTEM; SYNAPTIC TRANSMISSION;

EID: 74949089548     PISSN: 03636135     EISSN: 15221539     Source Type: Journal    
DOI: 10.1152/ajpheart.00400.2009     Document Type: Article

References (62)

1. Benter IF, Yousif MHM, Dhaunsi GS, Kaur J, Chappell MC, Diz DI. Angiotensin-(1-7) prevents activation of NADPH oxidase and renal vascular dysfunction in diabetic hypertensive rats. Am J Nephrol 28: 25-33, 2008.
2. Brosnihan KB. Effect of the angiotensin-(1-7) peptide on nitric oxide release. Am J Cardiol 82: 17S-19S, 1998.
3. Brosnihan KB, Li P, Tallant EA, Ferrario CM. Angiotensin-(1-7): a novel vasodilator of the coronary circulation. Biol Res 31: 227-234, 1998.
4. Byku M, Macarthur H, Westfall TC. Nerve stimulation induced over-flow of neuropeptide Y and modulation by angiotensin II in spontaneously hypertensive rats. Am J Physiol Heart Circ Physiol 295: H2188-H2197, 2008.
5. Campese VM, Ye S, Zhong H. Downregulation of neuronal nitric oxide synthase and interleukin-1 beta mediates angiotensin II-dependent stimulation of sympathetic nerve activity. Hypertension 39: 519-524, 2002.
6. Carey RM, Siragy HM. Newly recognized components of the reninangiotensin system: potential roles in cardiovascular and renal regulation. Endocr Rev 24: 261-271, 2003.
7. Cavadas C, Grand D, Mosimann F, Cotrim MD, Fontes Ribeiro CA, Brunner HR, Grouzmann E. Angiotensin II mediates catecholamine and neuropeptide Y secretion in human adrenal chromaffin cells through the AT1 receptor. Regul Pept 111: 61-65, 2003.
8. de Champlain J, Karas M, Toal C, Nadeau R, Larochelle P. Effects of antihypertensive therapies on the sympathetic nervous system. Can J Cardiol 15, Suppl A: 8A-14A, 1999.
9. de Champlain J. Pre- and postsynaptic adrenergic dysfunctions in hypertension. J Hypertens Suppl 8: S77-S85, 1990.
10. Crackower MA, Sarao R, Oudit GY, Yagil C, Kozieradzki I, Scanga SE, Oliveira-dos-Santos AJ, da Costa J, Zhang L, Pei Y, Scholey J, Ferrario CM, Manoukian AS, Chappell MC, Backx PH, Yagil Y, Penninger JM. Angiotensin-converting enzyme 2 is an essential regulator of heart function. Nature 417: 822-828, 2002.
11. Dubinion JH, Mi Z, Jackson EK. Role of renal sympathetic nerves in regulating renovascular responses to angiotensin II in spontaneously hypertensive rats. J Pharmacol Exp Ther 317: 1330-1336, 2006.
12. Ferrario CM. Angiotension-(1-7) and antihypertensive mechanisms. J Nephrol 11: 278-283, 1998.
13. Ferrario CM, Mohara O, Ueno Y, Brosnihan KB. Hemodynamic and neurohormonal changes in the development of DOC hypertension in the dog. Am J Med Sci 295: 352-359, 1988.
14. Ferrario CM, Trask AJ, Jessup JA. Advances in biochemical and functional roles of angiotensin-converting enzyme 2 and angiotensin-(1-7) in regulation of cardiovascular function. Am J Physiol Heart Circ Physiol 289: H2281-H2290, 2005.
15. Ferrario CM, Jessup J, Gallagher PE, Averill DB, Brosnihan KB, Ann Tallant E, Smith RD, Chappell MC. Effects of renin-angiotensin system blockade on renal angiotensin-(1-7) forming enzymes and receptors. Kidney Int 68: 2189-2196, 2005.
16. Flaa A, Mundal HH, Eide I, Kjeldsen S, Rostrup M. Sympathetic activity and cardiovascular risk factors in young men in the low, normal, and high blood pressure ranges. Hypertension 47: 396-402, 2006.
17. Gironacci MM, Adler-Graschinsky E, Pena C, Enero MA. Effects of angiotensin II and angiotensin-(1-7) on the release of [3H]norepinephrine from rat atria. Hypertension 24: 457-460, 1994.
18. Gironacci MM, Valera MS, Yujnovsky I, Peña C. Angiotensin-(1-7) inhibitory mechanism of norepinephrine release in hypertensive rats. Hypertension 44: 783-787, 2004.
19. Gironacci MM, Yujnovsky I, Gorzalczany S, Taira C, Peña C. Angiotensin-(1-7) inhibits the angiotensin II-enhanced norepinephrine release in coarcted hypertensive rats. Regul Pept 118: 45-49, 2004.
20. Goldstein DS. Plasma norepinephrine in essential hypertension. A study of the studies. Hypertension 3: 48-52, 1981.
21. Gradin KA, Li JY, Andersson O, Simonsen U. Enhanced neuropeptide Y immunoreactivity and vasoconstriction in mesenteric small arteries from spontaneously hypertensive rats. J Vasc Res 40: 252-265, 2003.
22. Grobecker G, Roizen MF, Weise V, Saavedra JM, Kopin IJ. Letter: Sympathoadrenal medullary activity in young, spontaneously hypertensive rats. Nature 258: 267-268, 1975.
23. Huidobro-toro J, Donoso MV. Sympathetic co-transmission: the coordinated action of ATP and noradrenaline and their modulation by neuropeptide Y in human vascular neuroeffector junctions. Euro Journal of Pharmacol 500: 27-35, 2004.
24. Iyer SN, Ferrario CM, Chappell MC. Angiotensin-(1-7) contributes to the antihypertensive effects of blockade of the renin-angiotensin system. Hypertension 31: 356-361, 1998.
25. Kawasaki H, Cline WH Jr, Su C. Enhanced angiotensin-mediated facilitation of adrenergic neurotransmission in spontaneously hypertensive rats. J Pharmacol Exp Ther 221: 112-116, 1982.
26. Kawasaki H, Cline WH Jr, Su C. Enhanced presynaptic beta adrenoceptor-mediated modulation of vascular adrenergic neurotransmission in spontaneously hypertensive rats. J Pharmacol Exp Ther 223: 721-728, 1982.
27. Kohara K, Brosnihan KB, Ferrario CM. Angiotensin(1-7) in the spontaneously hypertensive rat. Peptides 14: 883-891, 1993.
28. Kolo LL, Westfall TC, Macarthur H. Nitric oxide decreases the biological activity of norepinephrine resulting in altered vascular tone in the rat mesenteric arterial bed. Am J Physiol Heart Circ Physiol 286: H296-H303, 2004.
29. Kolo LL, Westfall TC, Macarthur H. Modulation of neurotransmitter release by NO is altered in mesenteric arterial bed of spontaneously hypertensive rats. Am J Physiol Heart Circ Physiol 287: H1842-H1847, 2004.
30. Koka V, Huang XR, Chung AC, Wang W, Truong LD, Lan HY. Angiotensin II up-regulates angiotensin I-converting enzyme (ACE), but down-regulates ACE2 via the AT1-ERK/p38 MAP kinase pathway. Am J Pathol 172: 1174-1183, 2008.
31. Krum H, Lambert E, Windebank E, Campbell DJ, Esler M. Effect of angiotensin II receptor blockade on autonomic nervous system function in patients with essential hypertension. Am J Physiol Heart Circ Physiol 290: H1706-H1712, 2006.
32. Li P, Chappell MC, Ferrario CM, Brosnihan KB. Angiotensin-(1-7) augments bradykinin-induced vasodilation by competing with ACE and releasing nitric oxide. Hypertension 29: 394-400, 1997.
33. Lundberg JM. Pharmacology of cotransmission in the autonomic nervous system: integrative aspects on amines, neuropeptides, adenosine triphosphate, amino acids and nitric oxide. Pharmacol Rev 48: 113-178, 1996.
34. Majewski H, Hedler L, Schurr C, Starke K. Modulation of noradrenaline release in the pithed rabbit: a role for angiotensin II. J Cardiovasc Pharmacol 6: 888-896, 1984.
35. Meldrum MJ, Xue CS, Badino L, Westfall TC. Angiotensin facilitation of noradrenergic neurotransmission in central tissues of the rat: effects of sodium restriction. J Cardiovasc Pharmacol 6: 989-995, 1984.
36. Meldrum MJ, Westfall TC. Angiotensin facilitation of 3H-norepinephrine release in central tissue of spontaneously hypertensive rats but not in Wistar-Kyoto rats: effects of sodium depletion. J Cardiovasc Pharmacol 8: 582-587, 1986.
37. Morris J, Gibbins IL. Co-transmission and Neuromodulation. In: Autonomic Neuroeffector Mechanisms, edited by Burnstock G, Hoyle CHV. Reading, PA: Hardwood Academic, 1992, p. 33-119.
38. Nagatsu T, Kato T, Numata Y, Keiko I, Umezawa H. Serum dopamine beta-hydroxylase activity in developing hypertensive rats. Nature 251: 630-631, 1974.
39. Nap AB, Balt JC, Mathy MJ, van Zwieten PA. AT1-receptor blockade and sympathetic neurotransmission in cardiovascular disease. Auton Autacoid Pharmacol 23: 285- 296, 2004.
40. Palermo A, Costantini C, Mara G, Libretti A. Role of the sympathetic nervous system in spontaneous hypertension: changes in central adrenoceptors and plasma catecholamine levels. Clin Sci (Lond) 61, Suppl 7: 195s-198s, 1981.
41. Paul M, Poyan Mehr A, Kreutz R. Physiology of local renin-angiotensin systems. Physiol Rev 86: 747-803, 2006.
42. Potter E. Neuropeptide Y as an autonomic transmitter. In: Novel Peripheral Neurotransmitters, edited by Bell C. New York: Pergamon, 1991, p. 81-112.
43. Raizada MK, Lu D, Sumners C. AT1 receptors and angiotensin actions in the brain and neuronal cultures of normotensive and hypertensive rats. Adv Exp Med Biol 377: 331-348, 1995.
44. Reinhart GA, Lohmeier TE, Hord CE Jr. Hypertension induced by chronic renal adrenergic stimulation is angiotensin dependent. Hypertension 25: 940-949, 1995.
45. Roizen MF, Weise V, Grobecker H, Kopin IJ. Plasma catecholamines and dopamine-beta-hydroxylase activity in spontaneously hypertensive rats. Life Sci 17: 283-288, 1975.
46. Roks AJ, van Geel PP, Pinto YM, Buikema H, Henning RH, de Zeeuw D, van Gilst WH. Angiotensin-(1-7) is a modulator of the human renin-angiotensin system. Hypertension 34: 296-301, 1999.
47. Santos RA, Simoes e Silva AC, Maric C, Silva DM, Machado RP, de Buhr I, Heringer-Walther S, Pinheiro SV, Lopes MT, Bader M, Mendes EP, Lemos VS, Campagnole-Santos MJ, Schultheiss HP, Speth R, Walther T. Angiotensin-(1-7) is an endogenous ligand for the G protein-coupled receptor Mas. Proc Natl Acad Sci USA 100: 8258-8263, 2003.
48. Santos RA, Campagnole-Santos MJ, Andrade SP. Angiotensin-(1-7):an update. Regul Pept 91: 45-62, 2000.
49. Santos RA, Campagnole-Santos MJ. Central and peripheral actions of angiotensin-(1-7). Braz J Med Biol Res 27: 1033-1047, 1994.
50. Siragy HM, Carey RM. The subtype 2 (AT2) angiotensin receptor mediates renal production of nitric oxide in conscious rats. J Clin Invest 100: 264-269, 1997.
51. Siragy HM, Jaffa AA, Margolius HS. Bradykinin B2 receptor modulates renal prostaglandin E2 and nitric oxide. Hypertension 29: 757-762, 1997.
52. Solt VB, Brown MR, Kennedy B, Kolterman OG, Ziegler MG. Elevated insulin, norepinephrine, and neuropeptide Y in hypertension. Am J Hypertens 3: 823-828, 1990.
53. Starke K, Gothert M, Kilbinger H. Modulation of neurotransmitter release by presynaptic autoreceptors. Physiol Rev 69: 864-989, 1989.
54. Stegbauer J, Oberhauser V, Vonend O, Rump LC. Angiotensin-(1-7) modulates vascular resistance and sympathetic neurotransmission in kidneys of spontaneously hypertensive rats. Cardiovasc Res 61: 352-359, 2004.
55. Tipnis SR, Hooper NM, Hyde R, Karran E, Christie G, Turner AJ. A human homolog of angiotensin-converting enzyme. Cloning and functional expression as a captopril-insensitive carboxypeptidase. J Biol Chem 275: 33238-33243, 2000.
56. Tsutsumi Y, Matsubara H, Masaki H, Kurihara H, Murasawa S, Takai S, Miyazaki M, Nozawa Y, Ozono R, Nakagawa K, Miwa T, Kawada N, Mori Y, Shibasaki Y, Tanaka Y, Fujiyama S, Koyama Y, Fujiyama A, Takahashi H, Iwasaka T. Angiotensin II type 2 receptor overexpression activates the vascular kinin system and causes vasodilation. J Clin Invest 104: 925-935, 1999.
57. Westfall TC, Carpentier S, Chen X, Beinfeld MC, Naes L, Meldrum MJ. Prejunctional and postjunctional effects of neuropeptide Y at the noradrenergic neuroeffector junction of the perfused mesenteric arterial bed of the rat. J Cardiovasc Pharmacol 10: 716-722, 1987.
58. Westfall TC, JMQ, Meldrum MJ, Zhang S, Carptentier S, Naes L. Central and peripheral alterations in noradrenergic transmission in experimental hypertension: modulation by prejunctional receptors. J Cardiovas Pharm 10: S62-S67, 1987.
59. Xu P, Costa-Goncalves AC, Todiras M, Rabelo LA, Sampaio WO, Moura MM, Santos SS, Luft FC, Bader M, Gross V, Alenina N, Santos RA. Endothelial dysfunction and elevated blood pressure in MAS gene-deleted mice. Hypertension 51: 574-580, 2008.
60. Ye S, Zhong H, Yanamadala V, Campese VM. Renal injury caused by intrarenal injection of phenol increases afferent and efferent renal sympathetic nerve activity. Am J Hypertens 15: 717-724, 2002.
61. Zimmerman BG, Gomez J. Increased response to sympathetic stimulation in the cutaneous vasculature in presence of angiotensin. Int J Neuropharmacol 4: 185-193, 1965.
62. Zukowska-Grojec Z, Golczynska M, Shen GH, Torres-Duarte A, Haass M, Wahlestedt C, Myers AK. Modulation of vascular function by neuropeptide Y during development of hypertension in spontaneously hypertensive rats. Pediatr Nephrol 7: 845-852, 1993.